2022 Antibody Drug Conjugates Market Growth, Segmentation, Industry Analysis, Top Key Players | Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Immunomedics Inc., Oxford BioTherapeutics

The global antibody drug conjugates market size is expected to grow from $4.79 billion in 2021 to $5.90 billion in 2022 at a compound annual growth rate (CAGR) of 23.1%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The antibody drug conjugates market is expected to reach $13.06 billion in 2026 at a CAGR of 22%.

The Business Research Company offers the Antibody Drug Conjugates Global Market Report 2022 in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market's historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

Directly purchase the report here: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2569

The antibody-drug conjugates (ADCs) market consists of sales of antibody-drug conjugates. Antibody-drug conjugates are complex engineered therapeutics consisting of monoclonal antibodies, directed toward tumor-associated antigens, to which highly potent cytotoxic agents are attached using chemical linkers.

Some key antibody drug conjugates market players are Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Immunomedics Inc., Oxford BioTherapeutics, Pfizer Inc., Seattle GeneticsInc., Takeda Pharmaceutical Company Limited, Abbvie Inc. and Astellas Pharma/Agensys.

The countries covered in the global antibody drug conjugates market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global antibody drug conjugates market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Antibody drug conjugates Market Segmentation:
1) By Type: Monoclonal Antibodies, Linker, Drug/Toxin, Others
2) By Application: Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor, Others
3) By Product: Adcertis, Kadcyla, Others
4) By Technology: Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology, Others
5) By End-User: Hospital, Clinics, Others

See more on the report at https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report

The Report's Table Of Contents includes
1. Executive Summary
2. Antibody Drug Conjugates Market Characteristics
3. Antibody Drug Conjugates Market Trends And Strategies
4. Impact Of COVID-19 On Antibody Drug Conjugates
5. Antibody Drug Conjugates Market Size And Growth
……
27. Antibody Drug Conjugates Market Competitive Landscape And Company Profiles
28. Antibody Drug Conjugates Pipeline Analysis
29. Key Mergers And Acquisitions In The Antibody Drug Conjugates Market
30. Antibody Drug Conjugates Market Future Outlook and Potential Analysis

This report covers the trends and market dynamics of the antibody drug conjugates market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample of this report: https://www.thebusinessresearchcompany.com/sample.aspx?id=2569&type=smp

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our blog: http://blog.tbrc.info/
And follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

About Us:
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. It has published over 3000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

This release was published on openPR.